Samsung Debuts New Ultrasound Modality Geared Toward Women's Health and Urology
Combining enhanced imaging capabilities, workflow efficiencies and artificial intelligence (AI)-enabled technology to improve the diagnosis and management of health conditions in women, Samsung has launched the V6 ultrasound system.
Advances in artificial intelligence (AI) technology and image sharing tools with Samsung’s new V6 ultrasound platform may facilitate enhanced workflow efficiencies in the management of women’s health conditions.
Samsung noted that key advances with the V6 ultrasound system include:
• one-click fetal growth measurements with the semi-automated BiometryAssist™ feature;
• AI-enabled uterus measurements to help detect uterine-related abnormalities with UterineAssist™; and
• real-time image sharing between sonographers and referring physicians with the SonoSync™ feature.
The V6 ultrasound platform also features a miniER7 endocavity transducer, which gives clinicians a 180-degree field of view, a frequency range between 2 and 12 MHz, and design enhancements that may enhance patient comfort, according to Samsung.
“The V6 was developed with the clinical needs of women’s health and urology specifically in mind,” said Tracy Bury, a women’s health segment leader for Boston Imaging, the United States headquarters of Samsung’s digital radiography and ultrasound business. “We’re proud to offer a new product that is not only accessible to a broad group of clinicians but also has innovative, automated features that can make patient care simpler and more efficient.”
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Stroke MRI Study Assesses Impact of Motion Artifacts Upon AI and Radiologist Lesion Detection
July 16th 2025Noting a 7.4 percent incidence of motion artifacts on brain MRI scans for suspected stroke patients, the authors of a new study found that motion artifacts can reduce radiologist and AI accuracy for detecting hemorrhagic lesions.
